Furthermore, the SEER database lacks important information regarding LC predisposing factors (e.g., viral hepatitis, non-alcoholic fatty liver disease, or cirrhosis), cancer treatment (chemotherapy, quality of surgery), as well as alpha-fetoprotein levels. Here, AFP is linked to metabolic dysfunction-associated steatotic liver disease.